Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trial

Hsu Y.-C.Chen C.-Y.Chang I.-W.Chang C.-Y.Wu C.-Y.Lee T.-Y.MING-SHIANG WUBair M.-J.Chen J.-J.CHIEH-CHANG CHENTseng C.-H.Tai C.-M.Huang Y.-T.Ku W.-H.Mo L.-R.Lin J.-T.2022-02-182022-02-1820211473-3099https://www.scopus.com/inward/record.uri?eid=2-s2.0-85100640925&doi=10.1016%2fS1473-3099%2820%2930692-7&partnerID=40&md5=84e1addb924e940a4f15bfc41eaf0125https://scholars.lib.ntu.edu.tw/handle/123456789/594765[SDGs]SDG3Once-daily tenofovir disoproxil fumarate in treatment-naive Taiwanese patients with chronic hepatitis B and minimally raised alanine aminotransferase (TORCH-B): a multicentre, double-blind, placebo-controlled, parallel-group, randomised trialjournal article10.1016/S1473-3099(20)30692-7335243142-s2.0-85100640925